Colifaster® is indicated for the treatment of dyspeptic disorders, gastroenteric meteorism, aerophagia and gas colic in infants, children and adults; it can protect the biological intestinal flora as a mechanical barrier and regenerate it, inhibiting the attachment of pathogenic bacteria and at the same time to reduce the surface tension of air bubbles, which are formed in the gastro-intestinal tract.
Colifaster® is an association of Simethicone (40mg/ml) with a probiotic, Saccharomyces boulardii (2g).
While Simethicone helps to remove intestinal gas and to decrease pression in the gastrointestinal tract, Saccharomyces boulardii helps to restore and develop the natural intestinal flora, with an antagonistic effect against the proliferation of enteric pathogens.
Colifaster® is delivered in a 20 ml bottle with a pipette dropper for the Simethicone solution and a hermetic sachet with 2g of Saccharomyces boulardii, both packed in a carton box with information leaflet.
Colifaster® is a European Medical Device class IIa. Produced in the E.U. under ISO 13485.